Clinical Trial Update: Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological Suppression

View source ↗

Summary

A completed clinical trial evaluated how switching virologically suppressed HIV patients to NNRTI-based therapy affects quality of life.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Status: COMPLETED